Clinical trial Recruiting at 1 site Interventional Ages 35 to 75 Women only

Improving symptoms by removing the Essure contraceptive implant

Official title: Prospective Multicenter Study of the Improvement of Symptoms After Removal of the Essure® Contraceptive Implant

Run by Hospices Civils de Lyon · NCT06355713 · Data updated 2026-11-12

This study is testing if removing the Essure contraceptive implant can help women aged 35 to 75 who are having problems with the device feel better.

Quick facts

Study typeInterventional
Ages35 Years to 75 Years
SexWomen only
Enrollment444 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations10 sites (Angers and 9 other locations)
StatusRecruiting
StartedFebruary 17, 2025
Main results expectedApril 17, 2032
Study endsFebruary 17, 2037
Registry record updatedApril 13, 2026
Trial IDNCT06355713 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 35 to 75 with at least one Essure® implant who are symptomatic and scheduled for explantation.

Probably not a fit

Patients who do not have an Essure® implant or are asymptomatic may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of removing the Essure® contraceptive implant in women aged 35 to 75 who are experiencing symptoms related to the device. The study aims to assess symptom improvement following explantation through various surgical methods, including laparoscopy and robotic surgery. Participants will undergo MRI-PET examinations, blood and urine tests, and complete questionnaires to evaluate their health status pre- and post-surgery. The trial addresses a significant public health issue, as many women with these implants have not received the necessary treatment for their symptoms.

Why it matters

Potential benefit: If successful, this study could provide significant relief for women suffering from complications related to the Essure® implant.

How similar studies have gone: Previous studies have shown significant symptom improvement after explantation of the Essure® implant, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
* Inclusion Criteria \* :

ESSURE Group:

* woman aged 35 to 75
* patient with at least one Essure® implant
* surgical intervention planned because the patient is symptomatic: removal of the Essure® implant(s)
* planned intervention via vaginal route, laparoscopy, robotic surgery, or Transvaginal natural orifice transluminal endoscopic surgery (VNotes)
* patient having given free, informed and signed consent

Selection for MRI-PET examination:

* if the answer is "poor" or "bad" to the first question of the SF-12 pre-operatively
* no hysterectomy
* no analgesic treatment, or treatment stopped 48 hours before the examination
* no psychotropic treatment (anxiolytics, hypnotics (sleeping pills), antidepressants, mood stabilizers, neuroleptics)
* patient having given free, informed and signed consent

Control group:

* woman aged 35 to 75
* planned surgical intervention: salpingectomy with or without hysterectomy for benign indication
* planned intervention via vaginal route, laparoscopy, robotic surgery, or VNotes
* patient having given free, informed and signed consent

Selection for MRI-PET examination:

* age matching (+/- 5 years) with Essure® patients who have had an MRI-PET
* matching on surgical technique with Essure® patients who have had an MRI-PET: salpingectomy with or without hysterectomy
* no analgesic treatment, or treatment stopped 48 hours before the examination
* no psychotropic treatment (anxiolytics, hypnotics (sleeping pills), antidepressants, mood stabilizers, neuroleptics)
* patient having given free, informed and signed consent

  * Exclusion Criteria \* :

ESSURE Group:

* asymptomatic patient
* planned intervention by laparotomy
* patient potentially exposed to other heavy metals: wearer of metallic orthopedic equipment (hip or knee prosthesis, etc.), wearer of coronary stent, or tubal ligation clip
* inability to understand the information given
* persons deprived of liberty by a judicial or administrative decision
* people undergoing psychiatric care
* people admitted to a health or social establishment for purposes other than research
* adults subject to a legal protection measure (guardianship, curatorship)
* people not affiliated to a social security scheme or beneficiaries of a similar scheme
* person participating in another interventional research that may interfere with the research

Selection for MRI-PET examination:

* claustrophobia
* dosimetry of all radiological examinations over the past year not acceptable

Control Group :

* current pregnancy
* patient with cancer
* patient who has already had an Essure® implant removed
* patient potentially exposed to heavy metals: wearer of metallic orthopedic equipment (hip or knee prosthesis, etc.), wearer of coronary stent, or tubal ligation clip
* planned intervention by laparotomy
* inability to understand the information given
* persons deprived of liberty by a judicial or administrative decision
* people undergoing psychiatric care
* people admitted to a health or social establishment for purposes other than research
* adults subject to a legal protection measure (guardianship, curatorship)
* people not affiliated to a social security scheme or beneficiaries of a similar scheme
* person participating in another interventional research that may interfere with the research

Selection for MRI-PET examination:

* claustrophobia
* dosimetry of all radiological examinations over the past year not acceptable

Where it's running

  • Hôpital Femme Mère Enfant (Hospices Civils de Lyon)
    Bron, France
    Recruiting
  • CHU de Angers
    Angers, France
    Not yet recruiting
  • Hôpital Bicêtre
    Le Kremlin-Bicêtre, France
    Not yet recruiting
  • Hôpital Jeanne de Flandres
    Lille, France
    Not yet recruiting
  • Hôpital de La Conception
    Marseille, France
    Not yet recruiting
  • Institut Mère Enfant Alix de Champagne, CHU Reims
    Reims, France
    Not yet recruiting
Show 4 more locations
  • CHU de Rouen
    Rouen, France
    Not yet recruiting
  • Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
    Strasbourg, France
    Not yet recruiting
  • Hôpital Paule de Viguier, CHU de Toulouse
    Toulouse, France
    Not yet recruiting
  • Hôpital André Mignot, Centre Hospitalier de Versailles
    Versailles, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.